Oncological Resectability Criteria for Hepatocellular Carcinoma in the Era of Novel Systemic Therapies: The Japan Liver Cancer Association and Japanese Society of Hepato-Biliary-Pancreatic Surgery Expert Consensus Statement 2023

Recent advances in systemic therapy for hepatocellular carcinoma (HCC) have led to debates about the feasibility of combination therapies, such as systemic therapy combined with surgery or transarterial chemoembolization, for patients with advanced HCC. However, a lack of consensus on the oncologica...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Keiichi Akahoshi, Junichi Shindoh, Minoru Tanabe, Shun‐ichi Ariizumi, Susumu Eguchi, Yukiyasu Okamura, Masaki Kaibori, Shoji Kubo, Mitsuo Shimada, Akinobu Taketomi, Nobuyuki Takemura, Hiroaki Nagano, Masafumi Nakamura, Kiyoshi Hasegawa, Etsuro Hatano, Tomoharu Yoshizumi, Itaru Endo, Norihiro Kokudo
Materyal Türü: Artigo
Dil:İngilizce
Baskı/Yayın Bilgisi: 2024
Online Erişim:https://doi.org/10.1159/000538627
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!